期刊文献+

经尿道前列腺电汽化切除加雄激素阻断治疗晚期前列腺癌 被引量:17

Treatment of late prostatic cancer by prostatectomy after castration and pharmacotherapy (a report of 31 cases)
下载PDF
导出
摘要 目的 探讨经尿道前列腺电汽化切除加雄激素阻断治疗晚期前列腺癌的临床疗效.方法 对31例前列腺癌晚期(D)患者采用经尿道前列腺电汽化切除及睾丸切除术,术后3~5 d口服氟他胺做全雄激素阻断以及氟他胺加达菲林的药物去势治疗.结果 随访3~42个月,生存者29例,2例患者生存超过5年,20例超过1年.其中7例骨转移病灶减少,6例骨痛患者治疗后疼痛消失.前列腺特异性抗原(PSA)从术前的75.37 μg/L降至1.34μg/L(术后1个月),3个月后降为0.27μg/L.B超、胸片、骨扫描未见新的转移灶.结论 经尿道前列腺癌电汽化切除加全雄激素阻断治疗晚期前列腺癌具有较好的临床疗效. Objective To evaluate the clinical effect of the treatment of late prostatic cancer by radical or palliative prostatectomy after castration and endocrine pharmacotherapy. Methods Radical (2 patients) or palliative (5) prostatectomy were performed in 7 patients with late prostatic cancer 3~6 months after castration and pharmacotherapy with Flutamide and DES. Results The obstruction of lower urinary tract was relieved, and the life quality was improved. Improvements in subjective symptoms, objectives signs,maximum flow rate and residual urine were significant. The survival time was lengthened. Mean PSA decreased from 75.37μg/L preoperatively to 1.34μg/L 3~6 months after treament. Bone pain in 6 patients disappeared. Conclusion Radical or palliative prostatectomy after castration and endocrine pharmacotherapy is believed to be safe and effective in relieving the urethal obstruction caused by advanced prostatic cancer.
出处 《现代泌尿外科杂志》 CAS 2005年第3期142-144,共3页 Journal of Modern Urology
关键词 前列腺癌 电汽切除术 睾丸切除术 全雄激素阻断 晚期 尿道 肿瘤 prostatic cancer prostatectomy orchiectomy androgen antagonists
  • 相关文献

参考文献10

  • 1邓杰 缪迁.上海男性泌尿生殖系肿瘤发病死亡分析[J].中华泌尿外科杂志,1982,3:77-80.
  • 2单玉喜,颜纯海,孙传洋.经尿道前列腺电气化治疗晚期前列腺肿瘤所致尿道梗阻[J].苏州医学院学报,2000,20(10):927-928. 被引量:4
  • 3周志耀,戴玉田.根治性前列腺切除术治疗前列腺癌[J].中华泌尿外科杂志,1993,14(3):163-165. 被引量:34
  • 4Labrie F, Cusan L, Gonezj L, et al. Long trem neoadjuvant and adjuvant combined androgen blocked is needed for efficacy of treatment in localized prostate cancer [J]. Mol Urol, 1997,1:253-263.
  • 5Prehen RT. On the prevention and therapy of prostate cancer by androgen administration [J]. Cancer Res, 1999,59:4161-4164.
  • 6Kennealey GT, Barrington J, Furr A. Use of nonsteroidal anti-an-drogen Casodexin advanced prostate cancer [J]. Urol Clin North Am, 1991,18:99.
  • 7Dupont A, CusanL, L abrie F. Response to flutamide with draw alin advanced prostate cancer in progression under combination thera-py [J]. J Urol, 1993,150:908.
  • 8Labrie F, Cusan L, Comez JL, et al. Dow staging by combination therapy with flutamide and an LHRH agonist before redical prostatectomy [J]. Cancer Surv, 1995, 23:149-156.
  • 9王忠棠,周志耀,鲁德生,吴幸辰,杨立.晚期前列腺癌致后尿道梗阻的治疗(附10例报告)[J].临床泌尿外科杂志,1996,11(2):75-77. 被引量:26
  • 10马腾骧. 现代泌尿外科学 [M]. 天津:天津科学技术出版社, 2000.530.

二级参考文献3

  • 13,David L.Minimally invasive treatment of benign prostatic hyperplasia.Campbell'surology,7th ed(Vol.2),Philadelphia,1998∶1497
  • 2周志耀,江苏医药,1985年,8卷,412页
  • 3顾方六,孔祥田,山岗志,邓方明,王行环,夏同礼,马文香.良性前列腺增生和前列腺癌在中国发病情况的研究[J]中国肿瘤,1997(10).

共引文献60

同被引文献62

引证文献17

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部